KBC Group’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $118K | Buy |
1,992
+558
| +39% | +$36.2K | ﹤0.01% | 1230 |
|
|
2025
Q4 | $88K | Hold |
1,434
| – | – | ﹤0.01% | 1375 |
|
|
2025
Q3 | $89K | Hold |
1,434
| – | – | ﹤0.01% | 1335 |
|
|
2025
Q2 | $115K | Sell |
1,434
-765
| -35% | -$64K | ﹤0.01% | 1114 |
|
|
2025
Q1 | $189K | Buy |
2,199
+151
| +7% | +$12.4K | ﹤0.01% | 1107 |
|
|
2024
Q4 | $160K | Buy |
2,048
+452
| +28% | +$35.1K | ﹤0.01% | 1259 |
|
|
2024
Q3 | $115K | Hold |
1,596
| – | – | ﹤0.01% | 1199 |
|
|
2024
Q2 | $110K | Buy |
1,596
+301
| +23% | +$20.4K | ﹤0.01% | 1112 |
|
|
2024
Q1 | $94K | Hold |
1,295
| – | – | ﹤0.01% | 1157 |
|
|
2023
Q4 | $79K | Hold |
1,295
| – | – | ﹤0.01% | 1212 |
|
|
2023
Q3 | $74K | Sell |
1,295
-2,586
| -67% | -$156K | ﹤0.01% | 1154 |
|
|
2023
Q2 | $231K | Sell |
3,881
-262
| -6% | -$15.7K | ﹤0.01% | 893 |
|
|
2023
Q1 | $259K | Sell |
4,143
-242
| -6% | -$15.1K | ﹤0.01% | 903 |
|
|
2022
Q4 | $275K | Sell |
4,385
-244
| -5% | -$14K | ﹤0.01% | 878 |
|
|
2022
Q3 | $231K | Hold |
4,629
| – | – | ﹤0.01% | 919 |
|
|
2022
Q2 | $272K | Sell |
4,629
-2,356
| -34% | -$130K | ﹤0.01% | 897 |
|
|
2022
Q1 | $370K | Hold |
6,985
| – | – | ﹤0.01% | 888 |
|
|
2021
Q4 | $424K | Hold |
6,985
| – | – | ﹤0.01% | 910 |
|
|
2021
Q3 | $392K | Sell |
6,985
-6,985
| -50% | -$384K | ﹤0.01% | 924 |
|
|
2021
Q2 | $728K | Hold |
13,970
| – | – | ﹤0.01% | 979 |
|
|
2021
Q1 | $616K | Sell |
13,970
-1,166
| -8% | -$49K | ﹤0.01% | 1000 |
|
|
2020
Q4 | $2.9M | Hold |
15,136
| – | – | ﹤0.01% | 968 |
|
|
2020
Q3 | $550K | Sell |
15,136
-75,850
| -83% | -$2.82M | ﹤0.01% | 914 |
|
|
2020
Q2 | $3.42M | Buy |
90,986
+65,840
| +262% | +$2.63M | 0.01% | 593 |
|
|
2020
Q1 | $922K | Buy |
+25,146
| New | +$977K | 0.01% | 711 |
|
|
2017
Q3 | – | Sell |
-13,983
| Closed | -$738K | – | 1270 |
|
|
2017
Q2 | $738K | Sell |
13,983
-1,733
| -11% | -$92.9K | 0.01% | 862 |
|
|
2017
Q1 | $873K | Sell |
15,716
-45,655
| -74% | -$2.52M | 0.01% | 906 |
|
|
2016
Q4 | $3.2M | Sell |
61,371
-19,439
| -24% | -$938K | 0.03% | 508 |
|
|
2016
Q3 | $3.9M | Buy |
80,810
+7,061
| +10% | +$357K | 0.05% | 406 |
|
|
2016
Q2 | $4.09M | Buy |
73,749
+58,033
| +369% | +$3.2M | 0.06% | 355 |
|
|
2016
Q1 | $839K | Buy |
+15,716
| New | +$774K | 0.01% | 692 |
|
|
2015
Q3 | – | Sell |
-3,324
| Closed | -$154K | – | 1371 |
|
|
2015
Q2 | $154K | Hold |
3,324
| – | – | ﹤0.01% | 1172 |
|
|
2015
Q1 | $143K | Hold |
3,324
| – | – | ﹤0.01% | 1181 |
|
|
2014
Q4 | $115K | Buy |
+3,324
| New | +$110K | ﹤0.01% | 1301 |
|
Other funds holding PBH
AI
VPM
VCM
KBC Group's PBH Position: Q1 2026 in Review
KBC Group increased its Prestige Consumer Healthcare (PBH) stake by 39% in Q1 2026, buying an estimated $36.2K and bringing the position to 1,992 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #1230.
KBC Group first reported a position in PBH in Q4 2014 and has held it in 34 quarters since. The position peaked at $4.09M in Q2 2016. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.
- KBC Group held 1,992 shares of Prestige Consumer Healthcare worth $118K as of Q1 2026.
- KBC Group bought 558 Prestige Consumer Healthcare shares in Q1 2026, an estimated $36.2K.
- Prestige Consumer Healthcare made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1230 holding.
- KBC Group first reported a position in Prestige Consumer Healthcare in Q4 2014 and has held it in 34 quarters since.
- KBC Group's Prestige Consumer Healthcare position peaked at $4.09M in Q2 2016.
- 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.